Use of recombinant human thyroid stimulating hormone (rhTSH) in therapy of differentiated thyroid carcinoma (DTC) with Iodine-131(I-131), in patients (pts) already treated after T4 withdrawal.

被引：0
|
作者：
Ferreira, TC [1 ]
Sevilla, A [1 ]
Garrao, A [1 ]
Henriques, M [1 ]
Limbert, E [1 ]
Vieira, MR [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [41] Remnant ablation (RA) success and differentiated thyroid carcinoma (DTC) outcome in Stage III/IV patients: Recombinant human thyrotropin (rhTSH) vs. thyroid hormone withdrawal (THW)
    Vallejo, J.
    Mena, L.
    Galvez, M.
    Latre, J.
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [42] Recombinant human thyroid-stimulating hormone-aided scintigraphy - Comparison of imaging at multiple times after I-131 administration
    Sarkar, SD
    Afriyie, MO
    Palestro, CJ
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (05) : 392 - 395
  • [43] Radioiodine therapy after hormone withdrawal and recombinant human thyrotropin (rhTSH) after redifferentiation with isotretinoin in patients with dedifferentiated thyroid carcinoma.
    Sandrock, DH
    Kettner, BI
    Munz, DL
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 309P - 309P
  • [44] Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
    Signore, Alberto
    Campagna, Giuseppe
    Marinaccio, Jessica
    de Vitis, Marco
    Lauri, Chiara
    Berardinelli, Francesco
    Tofani, Anna
    Chianelli, Marco
    Borro, Marina
    Gentile, Giovanna
    Simmaco, Maurizio
    Colombini, Francesco
    Giovanetti, Anna
    Sgura, Antonella
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1515 - 1522
  • [45] Both serum thyroglobulin level after I-131 therapy and pattern of I-131 whole body scan should be considered together for the prediction of excellent response in the patients with differentiated thyroid carcinoma
    Jeong, Geum-Cheol
    Jeon, Su Bin
    Park, Hee Jeong
    Cho, Sang-Geon
    Kang, Sae-Ryung
    Kim, Jahae
    Kwon, Seong Young
    Min, Jung Joon
    Song, Ho-Chun
    Bom, Hee-Seung
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [46] Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer
    de Keizer, B
    Hoekstra, A
    Konijnenberg, MW
    de Vos, F
    Lambert, B
    van Rijk, PP
    Lips, CJM
    de Klerk, JMH
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (09) : 1549 - 1554
  • [47] Effective half-lives (Eff T1/2) of Iodine-131 in cervical (CL) and distant (DL) localisations of patients treated for differentiated thyroid cancer (DTC)?
    Bourgeois, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S111 - S111
  • [48] Chromatographic identification of endogenously radioiodinated iodothyronines in urine after iodine-131 whole-body-scintigraphy (WBS) in the follow-up of patients with differentiated thyroid carcinoma (DTC).
    Rendl, J
    Bier, D
    Blasl, C
    Freystadt, D
    Reiners, C
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 1127 - 1127
  • [49] Recombinant human thyroid-stimulating hormone vs thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer
    Plyku, Donika
    Hobbs, Robert
    Senthamizhchelvan, Srinivasan
    Atkins, Frank
    Van Nostrand, Douglas
    Sgouros, George
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [50] Long term follow up of paediatric and adolescent differentiated thyroid carcinoma patients treated with I-131 radioactive iodine therapy- A single center experience from India
    Ajit, Nimmagadda
    Bikkina, Prathyusha
    Thapa, Pradeeep
    Ali, Zakir
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
12345